Kenvue Partners with Mayo Clinic to Advance Colloidal Oat Skin Research

Simarna Kaur, PhD, discusses the new collaboration and Aveeno's focus on science-backed skin care solutions.

Mar. 30, 2026 at 7:49am

Got story updates? Submit your updates here. ›

Kenvue, the parent company of Aveeno, has signed a three-year collaboration with Mayo Clinic to advance scientific research on the brand's 'Triple Oat' for use on compromised skin. Simarna Kaur, PhD, senior director of R&D and head of Aveeno product development, discusses the new partnership, the history of Aveeno's work with colloidal oatmeal, and the brand's focus on science-backed skin care solutions.

Why it matters

The partnership with Mayo Clinic allows Aveeno to leverage the clinic's expertise and patient insights to further advance the science behind colloidal oatmeal and other key ingredients. This aligns with Aveeno's long-standing commitment to formulating products based on rigorous research and clinical studies.

The details

The collaboration between Aveeno and Mayo Clinic builds on a relationship that dates back to the 1940s and 1950s, when foundational research on colloidal oatmeal was conducted. Kaur says the organizations' shared mission of 'inspiring hope and promoting health' makes the partnership a natural fit. Going forward, the teams will work together on preclinical and clinical studies to further elucidate the benefits of Aveeno's 'Triple Oat' technology for compromised skin.

  • Aveeno and Mayo Clinic announced the new three-year collaboration earlier this month.
  • The American Academy of Dermatology (AAD) Meeting is currently underway in Denver, where Aveeno is presenting around 20 new research studies.

The players

Simarna Kaur

Senior director of R&D and head of Aveeno product development at Kenvue.

Mayo Clinic

A nonprofit organization committed to clinical practice, education, and research, with which Aveeno has had a long-standing relationship dating back to the 1940s and 1950s.

Got photos? Submit your photos here. ›

What they’re saying

“Mayo Clinic's mission statement of 'Inspiring hope and promoting health through integrated clinical practice, education and research,' is very closely aligned to the brand's formulation philosophy in creating science backed solutions for sensitive skin using the most effective elements of oat.”

— Simarna Kaur, Senior director of R&D and head of Aveeno product development at Kenvue

“As new scientific capabilities emerge in skincare, we're continuously pushing ourselves to further understand our key ingredients and technologies. Whether it's testing on different skin types or disease states with new clinical endpoints or preclinical models, there are always opportunities to learn more about ingredients that have been around for a long time.”

— Simarna Kaur, Senior director of R&D and head of Aveeno product development at Kenvue

What’s next

Aveeno and Mayo Clinic will work together on preclinical and clinical research programs to further advance the science on oat ingredients for compromised skin.

The takeaway

The partnership between Aveeno and Mayo Clinic demonstrates the brand's ongoing commitment to developing science-backed skin care solutions. By leveraging Mayo's expertise and patient insights, Aveeno can continue to push the boundaries of understanding around the benefits of colloidal oatmeal and other key ingredients.